Post Profile

Related Posts

U.S. FDA approves AstraZeneca's bladder cancer drug

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration on Monday granted accelerated approval to AstraZeneca Plc's immuno-oncology drug to treat a type of bladder cancer in patients whose disease progressed following chemotherapy.

AstraZeneca ovarian cancer drug slows disease markedly in study

Health : Reuters: Health

LONDON (Reuters) - AstraZeneca's ovarian cancer drug Lynparza slowed disease progression sharply in a closely watched clinical trial, boosting hopes for a product that belongs to a novel drug class called PARP inhibitors.

FDA approves expanded use of AstraZeneca cancer drug

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved expanded use of AstraZeneca Plc's cancer drug Lynparza to include patients with metastatic breast cancer whose disease is associated with a mutation of...

The Biotech Startup Taking on Pancreatic Cancer by Throwing Out the Rules

News : The Daily Beast

Photo Illustration by The Daily Beast Despite better diagnostics and new drugs, cancer continues to kill 8 million people every year. While certain cancers are caught early and treated effectively, many others go undetected and—once...

AstraZeneca is sued by Array BioPharma over cancer drug royalties

Health : Reuters: Health

NEW YORK (Reuters) - Array BioPharma Inc on Thursday sued AstraZeneca AB, accusing the pharmaceutical company of refusing to pay required royalties for a cancer drug after entering into an $8.5 billion collaboration with Merck & Co.


Copyright © 2016 Regator, LLC